Review Note
Last Update: 07/28/2024 09:22 PM
Current Deck: SK EBM Deck
PublishedCurrently Published Content
Text
Secondary prevention of CVD
The first-line therapy for lipid management in patients with chronic coronary disease is {{c1::high-intensity statin::therapy}}.
The first-line therapy for lipid management in patients with chronic coronary disease is {{c1::high-intensity statin::therapy}}.
Extra
There are too many secondary prevention statin trials to keep track of; they are summarized in the Cholesterol Treatment Trialist (CTT) meta-analysis. High-intensity statins are favored on the basis of the TNT and PROVE-IT trials.
ankihub_id
f5eb47fb-08ca-4070-a331-44338f1bbd80
No published tags.
Pending Suggestions
No pending suggestions for this note.